Stryker is listed as a key player in the Knee Replacement Surgery Market, alongside companies based in Switzerland, Germany, and India.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Stryker is listed as a key player in the Knee Replacement Surgery Market, alongside companies based in Switzerland, Germany, and India.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Stryker's market presence is being driven by Mako placements and organic growth within the neurotechnology segment.Sub-event
Stryker is identified as a key player in the global knee replacement surgery market.1 source
Keep exploring
The entities involved
-
Stryker Corporation
American medical technologies company
-
Switzerland
country in Central Europe
Related events
- Stryker Corporation, Boston Scientific, and Medtronic plc are competing in the medical device market.
- Stryker Corporation and Microbot Medical are two healthcare companies that are currently competing for investment in the market.
- AC Immune, headquartered in Lausanne, Switzerland, is a company that trades on the Nasdaq exchange and maintains a subsidiary in Boston.
- Samsung Biologics utilized a Swiss subsidiary to make an offer.
Coverage
Newest first; wire copies grouped- GlobeNewswireKnee Replacement Surgeries Industry Report 2025-2030 - Osteoarthritis & Rheumatoid Arthritis Led Applications in 2024 Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Knee Replacement Surgery Market b